Both in Biotechnology
Palisade Bio vs Protalix BioTherapeutics
Over the past year PALI returned −44.0% and PLX returned +7.1%; their daily moves had a correlation of 0.10.
PALI −44.0% PLX +7.1%Growth of $1, one year, split-adjusted
| Metric | PALI | PLX |
|---|---|---|
| Price | $1.12 | $2.56 |
| Market cap | $195.2M | $206.3M |
| Today | −3.45% | −1.16% |
| 1 month | −22.2% | −5.5% |
| 6 months | −47.4% | +20.2% |
| Year to date | −52.3% | +42.2% |
| 1 year | −42.3% | +13.3% |
| Revenue growth (YoY) | — | +27.1% |
| Gross margin | 100.0% | 61.0% |
| Net margin | −2114.8% | 19.0% |
| P/E (TTM) | — | 10.9× |
| Price / sales | 390.4× | 2.6× |
| Net cash | $125.2M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 44.7% |
| Short % of float | 18.3% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).